Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Neratinib|DRUG: Capecitabine
Sponsor: Puma Biotechnology, Inc.